Invesco Biotechnology & Genome ETF
PBE
PBE
74 hedge funds and large institutions have $113M invested in Invesco Biotechnology & Genome ETF in 2014 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $129M → $113M (-$16.2M)
Holders
74
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.1M | |
| 2 | +$2.44M | |
| 3 | +$1.08M | |
| 4 |
HBT
Hills Bank & Trust
North Liberty,
Iowa
|
+$865K |
| 5 |
Neuberger Berman Group
New York
|
+$364K |
Top Sellers
| 1 | -$4.64M | |
| 2 | -$4.27M | |
| 3 | -$4.09M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.42M |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$3.26M |